Surgical decompression for space-occupying cerebral infarction: outcomes at 3 years in the randomized HAMLET trial

Marjolein Geurts1, H Bart van der Worp, L Jaap Kappelle

  • 1Department of Neurology and Neurosurgery, UMC Utrecht Stroke Center, Utrecht, The Netherlands. m.geurts-2@umcutrecht.nl

Stroke
|July 23, 2013
PubMed

Insights

Surgical decompression for severe stroke patients showed sustained benefits in reducing death and improving quality of life at three years. However, it did not significantly improve functional outcomes compared to standard medical care.

Area of Science:

  • Neurology
  • Neurosurgery
  • Critical Care Medicine

Background:

  • Space-occupying hemispheric infarction is a severe stroke type.
  • Decompressive surgery is a potential treatment option.

Purpose of the Study:

  • To assess if the 1-year benefits of surgical decompression for hemispheric infarction are sustained at 3 years.

Main Methods:

  • A randomized trial (Hemicraniectomy After Middle cerebral artery infarction with Life-threatening Edema Trial) followed 64 patients.
  • Patients received either decompressive surgery or best medical treatment.
  • Outcomes measured at 3 years included functional status (modified Rankin Scale), mortality, quality of life, and living situation.

Main Results:

  • Surgery did not significantly improve functional outcomes at 3 years (absolute risk reduction 1%).
  • Decompressive surgery significantly reduced case fatality (absolute risk reduction 37%).
  • More surgically treated patients lived at home (absolute risk reduction 27%), and their quality of life improved between 1 and 3 years.

Conclusions:

  • The positive effects of decompressive surgery on reducing mortality and improving quality of life in hemispheric infarction are sustained at 3 years.
  • Surgical decompression did not improve functional outcomes at 3 years.
Abstract

Related Concept Videos